home / stock / adxn / adxn quote
Last: | $8 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $8 |
High: | $0 |
Low: | $0 |
Volume: | 30 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$8 | $0 | $8 | $0 | $0 | 30 | 07-26-2024 |
$8 | $0 | $8 | $0 | $0 | 45 | 07-25-2024 |
$8 | $8.17 | $8 | $8.17 | $8 | 351 | 07-24-2024 |
$8.12 | $8.1 | $8.12 | $8.288 | $7.94 | 2,043 | 07-23-2024 |
$8.06 | $8.175 | $8.06 | $8.175 | $7.97 | 8,542 | 07-22-2024 |
$8.1 | $8.02 | $8.1 | $8.18 | $8.02 | 700 | 07-19-2024 |
$8.01 | $8.299 | $8.01 | $8.299 | $8.01 | 3,661 | 07-18-2024 |
$8.2359 | $8.242 | $8.2359 | $8.27 | $8.2201 | 1,022 | 07-17-2024 |
$8.26 | $8.1 | $8.26 | $8.26 | $8.01 | 1,406 | 07-16-2024 |
$8.32 | $8.02 | $8.32 | $8.3999 | $8.02 | 1,691 | 07-15-2024 |
$8.3 | $8.315 | $8.3 | $8.36 | $8.2 | 1,025 | 07-12-2024 |
$8.4 | $8.4 | $8.4 | $8.4 | $8.4 | 201 | 07-11-2024 |
$8.34 | $8.34 | $8.34 | $8.34 | $8.34 | 310 | 07-10-2024 |
$8.3 | $8.2001 | $8.3 | $8.4 | $8.2001 | 686 | 07-09-2024 |
$8.4 | $8.1 | $8.4 | $8.4 | $8.1 | 1,649 | 07-08-2024 |
$8.67 | $8.1527 | $8.67 | $8.67 | $8.1527 | 953 | 07-05-2024 |
$7.84 | $0 | $7.84 | $0 | $0 | 18 | 07-03-2024 |
$7.84 | $7.97 | $7.84 | $8.29 | $7.84 | 3,472 | 07-02-2024 |
$7.8352 | $7.8352 | $7.8352 | $7.8352 | $7.8352 | 245 | 07-01-2024 |
$8.2202 | $8.2202 | $8.2202 | $8.2202 | $8.2202 | 304 | 06-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Addex Therapeutics Ltd Company Name:
ADXN Stock Symbol:
NASDAQ Market:
Addex Therapeutics Ltd Website:
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, an...
2024-07-19 15:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 15, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological...